dc.contributor.author | Konukoglu, Dihlar | |
dc.contributor.author | SENYIGIT, Abdulhalim | |
dc.contributor.author | Ugurlu, Serdal | |
dc.contributor.author | Tabak, Omur | |
dc.contributor.author | Uzun, Hafize | |
dc.contributor.author | ORBANOGLU, Timur | |
dc.contributor.author | Karadag, Aytac | |
dc.date.accessioned | 2021-03-06T10:53:05Z | |
dc.date.available | 2021-03-06T10:53:05Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | SENYIGIT A., Tabak O., ORBANOGLU T., Karadag A., Ugurlu S., Uzun H., Konukoglu D., "Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes", CLINICAL AND INVESTIGATIVE MEDICINE, cilt.40, 2017 | |
dc.identifier.issn | 0147-958X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_ec79eaca-9133-4191-bf7c-261474861c13 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/155262 | |
dc.identifier.uri | https://doi.org/10.25011/cim.v40i5.28624 | |
dc.description.abstract | Purpose: Hyperglycemia is the major risk factor for microvascular complications in type 2 diabetes mellitus (T2DM) patients. This randomized controlled clinical trial aimed to investigate T2DM patients with microvascular complications with regard to possible relations among serum clusterin (CLU), amylin, secreted frizzled-related protein-4 (SFRP-4), glucagon-like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP-4) activities. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND INVESTIGATIVE MEDICINE | |
dc.contributor.department | Univ Biruni , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 5 | |
dc.contributor.firstauthorID | 19625 | |